ALERTS / EMAIL REVIEW
Digest preview
The exact email HTML and plain-text fallback for Weekly AI summary · PHAT. Opening this page never creates a batch or contacts Resend.
Plain-text fallback
Phathom Pharmaceuticals Weekly company brief · Sep 12, 2026 – Oct 12, 2026 At a glance Observed headcount: 436, -6 (-1.4%) from 442 on Sep 12, 2026 to Oct 12, 2026. 9 new job postings first seen in the period. 0 inferred departures among 61 tracked employees. 49 of 61 had a successful workforce observation in the past seven days. Analyst read AI analysis could not be generated for this edition. The collected facts below are unchanged. Headcount Observed headcount: 436, -6 (-1.4%) from 442 on Sep 12, 2026 to Oct 12, 2026. New job postings (9 of 9 shown) Territory Sales Representative - Hialeah FL · Florida, United States · first seen Oct 7, 2026 Phathom Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of gastrointestinal (GI) diseases. With exclusive rights in the United States, Europe, and Canada to vonoprazan—a first-in-class potassium-competitive acid blocker (PCAB)—Phathom is working to transform the treatment of acid-related disorders. Strategic Account Specialist -- Orlando FL · Florida, United States · first seen Oct 7, 2026 Phathom Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of gastrointestinal (GI) diseases. With exclusive rights in the United States, Europe, and Canada to vonoprazan—a first-in-class potassium-competitive acid blocker (PCAB)—Phathom is working to transform the treatment of acid-related disorders. Territory Sales Representative - Cincinnati (West) OH · Ohio, United States · first seen Oct 5, 2026 Phathom Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of gastrointestinal (GI) diseases. With exclusive rights in the United States, Europe, and Canada to vonoprazan—a first-in-class potassium-competitive acid blocker (PCAB)—Phathom is working to transform the treatment of acid-related disorders. Chief of Staff and Strategic Program Management · Florham Park, New Jersey, United States · first seen Oct 3, 2026 Phathom Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of gastrointestinal (GI) diseases. With exclusive rights in the United States, Europe, and Canada to vonoprazan—a first-in-class potassium-competitive acid blocker (PCAB)—Phathom is working to transform the treatment of acid-related disorders. Territory Sales Representative - Cleveland (East) OH · Ohio, United States · first seen Oct 2, 2026 Phathom Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of gastrointestinal (GI) diseases. With exclusive rights in the United States, Europe, and Canada to vonoprazan—a first-in-class potassium-competitive acid blocker (PCAB)—Phathom is working to transform the treatment of acid-related disorders. Strategic Account Specialist -- Charleston SC · South Carolina, United States · first seen Sep 30, 2026 Phathom Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of gastrointestinal (GI) diseases. With exclusive rights in the United States, Europe, and Canada to vonoprazan—a first-in-class potassium-competitive acid blocker (PCAB)—Phathom is working to transform the treatment of acid-related disorders. Virtual Sales Representative · United States · first seen Sep 25, 2026 Phathom Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of gastrointestinal (GI) diseases. With exclusive rights in the United States, Europe, and Canada to vonoprazan—a first-in-class potassium-competitive acid blocker (PCAB)—Phathom is working to transform the treatment of acid-related disorders. Territory Sales Representative - Carrollton GA · Georgia, United States · first seen Sep 15, 2026 Phathom Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of gastrointestinal (GI) diseases. With exclusive rights in the United States, Europe, and Canada to vonoprazan—a first-in-class potassium-competitive acid blocker (PCAB)—Phathom is working to transform the treatment of acid-related disorders. Territory Sales Representative - Indianapolis (South) IN · Indiana, United States · first seen Sep 15, 2026 Phathom Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of gastrointestinal (GI) diseases. With exclusive rights in the United States, Europe, and Canada to vonoprazan—a first-in-class potassium-competitive acid blocker (PCAB)—Phathom is working to transform the treatment of acid-related disorders. People 0 inferred departures among 61 tracked employees. 49 of 61 had a successful workforce observation in the past seven days. Coverage notes Headcount reflects provider observations. Posting dates are first-seen dates; openings do not establish net hiring. Job descriptions, when shown, are source excerpts. Review company evidence: https://workforce-signals.nickmattiacci.com/companies/phathom-pharmaceuticals